Fibromyalgia, chronic fatigue syndrome, and myofascial pain syndrome

被引:51
作者
Buskila, D [1 ]
机构
[1] Ben Gurion Univ Negev, Fac Hlth Sci, Soroka Med Ctr, Beer Sheva, Israel
关键词
D O I
10.1097/00002281-200103000-00005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The prevalence of chronic widespread pain in the general population in Israel was comparable with reports from the USA, UK, and Canada. Comorbidity with fibromyalgia (FM) resulted in somatic hyperalgesia in patients with irritable bowel syndrome. One sixth of the subjects with chronic widespread pain in the general population were also found to have a mental disorder. Mechanisms involved in referred pain, temporal summation, muscle hyperalgesia, and muscle pain at rest were attenuated by the N-methyl-D-aspartate (NMDA) antagonist, ketamine, in FM patients, Delayed corticotropin release, after interleukin-6 administration, in FM was shown to be consistent with a defect in hypothalamic corticotropin-releasing hormone neural function. The basal autonomic state of FM patients was characterized by increased sympathetic and decreased parasympathetic systems tones. The severity of functional impairment as assessed by the Medical Outcome Survey Short Form (SF-36) discriminated between patients with widespread pain alone and FM patients. Chronic fatigue syndrome (CFS) occurred in about 0.42% of a random community-based sample of 28,673 adults in Chicago, Illinois. A significant clinical overlap between CFS and FM was reported. Cytokine dysregulation was not found to be a singular or dominant factor in the pathogenesis of CFS, A favorable outcome of CFS in children was reported; two thirds recovered and resumed normal activities, No major therapeutic trials in FM and CFS were reported over the past year, (C) 2001 Lippincott Williams & Wilkins, Inc.
引用
收藏
页码:117 / 127
页数:11
相关论文
共 74 条
[1]   Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder [J].
Aaron, LA ;
Burke, MM ;
Buchwald, D .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (02) :221-227
[2]   Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients [J].
Ablashi, DV ;
Eastman, HB ;
Owen, CB ;
Roman, MM ;
Friedman, J ;
Zabriskie, JB ;
Peterson, DL ;
Pearson, GR ;
Whitman, JE .
JOURNAL OF CLINICAL VIROLOGY, 2000, 16 (03) :179-191
[3]  
Akkasilpa S, 2000, J RHEUMATOL, V27, P671
[4]   Chronic fatigue syndrome and primary fibromyalgia syndrome as recognized by GPs [J].
Bazelmans, E ;
Vercoulen, JHMM ;
Swanink, CMA ;
Fennis, JFM ;
Galama, JMD ;
van Weel, C ;
van der Meer, JWM ;
Bleijenberg, G .
FAMILY PRACTICE, 1999, 16 (06) :602-604
[5]  
Benjamin S, 2000, ARTHRITIS RHEUM-US, V43, P561, DOI 10.1002/1529-0131(200003)43:3<561::AID-ANR12>3.0.CO
[6]  
2-O
[7]   The T102C polymorphism of the 5-HT2A-receptor gene in fibromyalgia [J].
Bondy, B ;
Spaeth, M ;
Offenbaecher, M ;
Glatzeder, K ;
Stratz, T ;
Schwarz, M ;
de Jonge, S ;
Krüger, M ;
Engel, RR ;
Färber, L ;
Pongratz, DE ;
Ackenheil, M .
NEUROBIOLOGY OF DISEASE, 1999, 6 (05) :433-439
[8]   Fibromyalgia syndrome in men [J].
Buskila, D ;
Neumann, L ;
Alhoashle, A ;
Abu-Shakra, M .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2000, 30 (01) :47-51
[9]  
Buskila D, 2000, J RHEUMATOL, V27, P1521
[10]   Acute phase responses and cytokine secretion in chronic fatigue syndrome [J].
Cannon, JG ;
Angel, JB ;
Ball, RW ;
Abad, LW ;
Fagioli, L ;
Komaroff, AL .
JOURNAL OF CLINICAL IMMUNOLOGY, 1999, 19 (06) :414-421